Trials / Terminated
TerminatedNCT03827564
Goblet Cell Degranulation Produced by Intranasal Tear Neurostimulator (ITN) in Dry Eye Disease
Goblet Cell Degranulation Produced by Nasal Neurostimulation: A Randomized, Controlled Study in Patients With Dry Eye Disease
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate goblet cell degranulation following acute use of the Intranasal Tear Neurostimulator in participants with dry eye.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Intranasal Tear Neurostimulator (ITN) [TrueTear®] | The ITN applies a small electrical current to the nasal cavities to gently activate the body's natural tear production system. |
Timeline
- Start date
- 2019-06-24
- Primary completion
- 2020-06-08
- Completion
- 2020-06-08
- First posted
- 2019-02-01
- Last updated
- 2021-08-16
- Results posted
- 2021-08-16
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03827564. Inclusion in this directory is not an endorsement.